Sponsor: Rubicon Genomics
Recording Date: 2/19/2014
Recording Time: 1 hour
Dr. Martin Hirst and his research team are focusing on the development and improvement of molecular assays and bioinformatics tools to study the epigenetic causes of human diseases and to discover new targets for potential cures. As the Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre, and Assistant Professor at the University of British Columbia, Dr. Hirst is the epigenomic lead on several cancer research initiatives and a contributing member to national and international epigenomics consortia, such as the REMC, IHEC, and CEEHRC .
His rapidly expanding team is in need of a highly motivated postdoctoral fellow, with experience in computational epigenomics. The successful candidate will be involved in the development and optimization of computational tools for the epigenetic analysis of e.g. bisulfite, hydroxybisulite, chromatin immunoprecipitation, and tether chromatin conformation capture sequencing data. As part of larger cancer research initiatives, s/he will conduct computational primary and higher order analyses of epigenomics cancer data in order to reveal the disease causing mechanisms and identify targets for potential therapeutic interventions.
The successful candidate will hold a Ph.D. in bioinformatics or closely related area and will have experience in functional genomics or epigenomics. Ability to manage and analyze large biological data sets coming from next generation sequencing is a must, as is working knowledge of algorithms and statistics, and the ability to interact and communicate within a multidisciplinary research team.
Applicants should submit a cover letter explaining their qualifications and their interest in this position, curriculum vitae and the names and contact information for two individuals who could provide letters of recommendation. Applications and any inquiries should be sent to email@example.com.